Ravata’s proprietary platform is the first of its kind to extract electrical properties from embryos. Capable of identifying differences in cells that would otherwise appear identical the platform will improve clinical IVF success rates from the current failure rate of 70%.
Ravata Solutions is using its existing Lab-on-Chip platform to assist clinicians in ranking and selecting embryos for increased pregnancy rates through the identification of:
Damage from Cryo-Preservation
All cells are non-destructively analyzed with the system having been tested using over 6,000 embryos resulting in 300+ successful pregnancies in mouse models.